Kindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz® (mirtazapine transdermal ointment) for Cats Experiencing Poor Appetite and Weight Loss


SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ — Kindred Biosciences, Inc. (Nasdaq: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use…


Author: HEDGE

Executive Editor and Founder of Hedge Was Founded in January 22, 2008. Learn more about HEDGEaccordingly